[ Price : $8.95]
Federal Register notice: FDA announces a 5/26-27 workshop entitled FDA Science Forum 2021.[ Price : $8.95]
Federal Register notice: FDA amends its electronic import entries regulation to correct the statutory citation in the sections of ...[ Price : $8.95]
CDRH director Jeffrey Shuren describes the Centers Medical Device Development Tools program and Catalog of Regulatory Science Tool...[ Price : $8.95]
Three university experts say their advisory committee experience with Biogens aducanumab shows the value in randomized clinical tr...[ Price : $8.95]
FDA says studies found an increased risk of heart arrhythmias in patients with heart disease who take GlaxoSmithKlines Lamictal or...[ Price : $8.95]
An FDA safety communication says there is a higher risk of complications in breast reconstruction using two specific brands of ace...[ Price : $8.95]
FDA approves an expanded indication for Jazz Vyxeos to include pediatric patients aged one and older.[ Price : $8.95]
Evive Biotech submits a BLA for Ryzneuta, indicated for treating chemotherapy-induced neutropenia.